Why the study?
Does heparin-lock solution improve catheter patency in patients with central venous catheters?
Does heparin-lock solution improve catheter patency in patients with central venous catheters?
Despite growing concerns, heparin-lock solution remains the only commercially available product to maintain central venous catheter patency, requiring careful patient assessment before abandonment.
Answers are grounded in this paper and cite their sources.
Requires careful assessment before abandoning heparin-lock amid concerns; leaves open need for alternative commercial patency agents.
Traditionally, heparin-lock solution has been used with all central venous catheters. The introduction of new technology calling for the elimination of heparin and the growing concerns about the use of heparin have caused many health care professionals to question its continued use for this purpose. This literature review attempts to answer the most common questions using available research; however, there continues to be more questions than answers. At present, it appears that some farm of anticoagulant will produce more patent catheters, and heparin-lock solution is the only product commercially available. This situation drives the need for a careful assessment of patients' needs prior to abandoning the use of heparin.
No takes yet. Share an insight, caveat, or question.
Lynn Hadaway (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: